Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity
Abstract Background Defective phagocytosis in alveolar macrophages is associated with chronic obstructive pulmonary disease (COPD). Transient receptor potential cation channel subfamily V member 2 (TRPV2), a type of nonselective cation channel pertinent to diverse physiological functions, regulates...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12890-019-0821-y |
id |
doaj-bf1e9297d75c4e1a92a4cb981f04780b |
---|---|
record_format |
Article |
spelling |
doaj-bf1e9297d75c4e1a92a4cb981f04780b2020-11-25T02:04:21ZengBMCBMC Pulmonary Medicine1471-24662019-03-0119111010.1186/s12890-019-0821-yReduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activityHiroaki Masubuchi0Manabu Ueno1Toshitaka Maeno2Koichi Yamaguchi3Kenichiro Hara4Hiroaki Sunaga5Hiroki Matsui6Masahiro Nagasawa7Itaru Kojima8Yuko Iwata9Shigeo Wakabayashi10Masahiko Kurabayashi11Department of Allergy and Respiratory Medicine, Gunma University Graduate School of MedicineDepartment of Allergy and Respiratory Medicine, Gunma University Graduate School of MedicineDepartment of Allergy and Respiratory Medicine, Gunma University Graduate School of MedicineDepartment of Allergy and Respiratory Medicine, Gunma University Graduate School of MedicineDepartment of Allergy and Respiratory Medicine, Gunma University Graduate School of MedicineDepartment of Cardiovascular Medicine, Gunma University Graduate School of MedicineDepartment of Laboratory Sciences, Gunma University Graduate School of Health SciencesInstitute for Molecular and Cellular Regulation, Gunma UniversityInstitute for Molecular and Cellular Regulation, Gunma UniversityDepartment of Molecular Physiology, National Cerebral and Cardiovascular Center Research InstituteDepartment of Pharmacology, Osaka Medical CollegeDepartment of Allergy and Respiratory Medicine, Gunma University Graduate School of MedicineAbstract Background Defective phagocytosis in alveolar macrophages is associated with chronic obstructive pulmonary disease (COPD). Transient receptor potential cation channel subfamily V member 2 (TRPV2), a type of nonselective cation channel pertinent to diverse physiological functions, regulates macrophage phagocytosis. However, the role of TRPV2 in COPD remains poorly understood. Here, we explored the role of TRPV2 in the development of COPD. Methods Macrophage TRPV2 expression and phagocytosis function were measured in MH-S cells (a murine alveolar macrophage cell line) and a cigarette smoke exposure mouse model. Results TRPV2 expression and phagocytosis function were reduced when MH-S cells were exposed to cigarette smoke extract (CSE). TRPV2 knockdown by siRNA decreased phagocytosis in MH-S cells. Consistently, TRPV2 expression was reduced in alveolar macrophages prepared from bronchoalveolar lavage samples of mice which were exposed to cigarette smoke for 2 months. In addition, the alveolar space was progressively enlarged during development in TRPV2 knockout (TRPV2KO) mice. Moreover, exposure to cigarette smoke for 2 months significantly induced alveolar space enlargement in TRPV2KO mice, but not in wild-type (WT) mice. The phagocytic function of alveolar macrophages from TRPV2KO mice was reduced, compared with macrophages from WT mice. Conclusions TRPV2 expression is profoundly downregulated in alveolar macrophages at early time points of cigarette smoke exposure. Reduced TRPV2-mediated phagocytic function renders the lung susceptible to cigarette smoke-induced alveolar space enlargement. TRPV2 may provide a therapeutic target for COPD induced by cigarette smoke.http://link.springer.com/article/10.1186/s12890-019-0821-yAlveolar macrophageChronic obstructive pulmonary disease (COPD)Cigarette smokePhagocytosisTransient receptor potential V2 (TRPV2) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hiroaki Masubuchi Manabu Ueno Toshitaka Maeno Koichi Yamaguchi Kenichiro Hara Hiroaki Sunaga Hiroki Matsui Masahiro Nagasawa Itaru Kojima Yuko Iwata Shigeo Wakabayashi Masahiko Kurabayashi |
spellingShingle |
Hiroaki Masubuchi Manabu Ueno Toshitaka Maeno Koichi Yamaguchi Kenichiro Hara Hiroaki Sunaga Hiroki Matsui Masahiro Nagasawa Itaru Kojima Yuko Iwata Shigeo Wakabayashi Masahiko Kurabayashi Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity BMC Pulmonary Medicine Alveolar macrophage Chronic obstructive pulmonary disease (COPD) Cigarette smoke Phagocytosis Transient receptor potential V2 (TRPV2) |
author_facet |
Hiroaki Masubuchi Manabu Ueno Toshitaka Maeno Koichi Yamaguchi Kenichiro Hara Hiroaki Sunaga Hiroki Matsui Masahiro Nagasawa Itaru Kojima Yuko Iwata Shigeo Wakabayashi Masahiko Kurabayashi |
author_sort |
Hiroaki Masubuchi |
title |
Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity |
title_short |
Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity |
title_full |
Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity |
title_fullStr |
Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity |
title_full_unstemmed |
Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity |
title_sort |
reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes copd in mice through impaired phagocytic activity |
publisher |
BMC |
series |
BMC Pulmonary Medicine |
issn |
1471-2466 |
publishDate |
2019-03-01 |
description |
Abstract Background Defective phagocytosis in alveolar macrophages is associated with chronic obstructive pulmonary disease (COPD). Transient receptor potential cation channel subfamily V member 2 (TRPV2), a type of nonselective cation channel pertinent to diverse physiological functions, regulates macrophage phagocytosis. However, the role of TRPV2 in COPD remains poorly understood. Here, we explored the role of TRPV2 in the development of COPD. Methods Macrophage TRPV2 expression and phagocytosis function were measured in MH-S cells (a murine alveolar macrophage cell line) and a cigarette smoke exposure mouse model. Results TRPV2 expression and phagocytosis function were reduced when MH-S cells were exposed to cigarette smoke extract (CSE). TRPV2 knockdown by siRNA decreased phagocytosis in MH-S cells. Consistently, TRPV2 expression was reduced in alveolar macrophages prepared from bronchoalveolar lavage samples of mice which were exposed to cigarette smoke for 2 months. In addition, the alveolar space was progressively enlarged during development in TRPV2 knockout (TRPV2KO) mice. Moreover, exposure to cigarette smoke for 2 months significantly induced alveolar space enlargement in TRPV2KO mice, but not in wild-type (WT) mice. The phagocytic function of alveolar macrophages from TRPV2KO mice was reduced, compared with macrophages from WT mice. Conclusions TRPV2 expression is profoundly downregulated in alveolar macrophages at early time points of cigarette smoke exposure. Reduced TRPV2-mediated phagocytic function renders the lung susceptible to cigarette smoke-induced alveolar space enlargement. TRPV2 may provide a therapeutic target for COPD induced by cigarette smoke. |
topic |
Alveolar macrophage Chronic obstructive pulmonary disease (COPD) Cigarette smoke Phagocytosis Transient receptor potential V2 (TRPV2) |
url |
http://link.springer.com/article/10.1186/s12890-019-0821-y |
work_keys_str_mv |
AT hiroakimasubuchi reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT manabuueno reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT toshitakamaeno reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT koichiyamaguchi reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT kenichirohara reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT hiroakisunaga reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT hirokimatsui reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT masahironagasawa reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT itarukojima reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT yukoiwata reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT shigeowakabayashi reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity AT masahikokurabayashi reducedtransientreceptorpotentialvanilloid2expressioninalveolarmacrophagescausescopdinmicethroughimpairedphagocyticactivity |
_version_ |
1724942878302535680 |